Profile data is unavailable for this security.
About the company
Fermentalg SA is a France-based industrial biotechnology company. It specializes in the development of a technology which is used to produce molecules of interest and bypasses conventional methods using petrochemicals and also industrial fish farming. The Company offers a solution to the gradual depletion of two key resources: wild fish and petroleum. The Company's technology allows it to target a range of markets, such as human nutrition, animal feed, green chemicals, cosmetics and biofuels.
- Revenue in EUR (TTM)12.78m
- Net income in EUR-11.54m
- Incorporated2009
- Employees63.00
- LocationFermentalg SA4 Rue RiviereLIBOURNE 33500FranceFRA
- Phone+33 557250220
- Websitehttps://www.fermentalg.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Plant Advanced Technologies PAT SA | 941.74k | 318.01k | 9.42m | 16.00 | 30.26 | 1.00 | 10.67 | 10.01 | 0.2776 | 0.2776 | 0.8377 | 8.38 | -- | -- | -- | 58,858.75 | -- | -1.51 | -- | -1.96 | 144.97 | 128.32 | 33.77 | -13.36 | 0.3156 | -- | 0.2867 | -- | 14.61 | 10.44 | 1,081.17 | -- | -- | -- |
| Oncodesign Precision Medicine Opm SA | 207.25k | 6.27m | 10.32m | 13.00 | 1.61 | 0.9735 | 1.58 | 49.80 | 0.3457 | 0.3457 | 0.0114 | 0.5732 | 0.0119 | -- | 0.2634 | 11,513.89 | 36.11 | -- | 54.21 | -- | 6,372.89 | -- | 3,026.21 | -- | 0.926 | 20.81 | 0.3859 | -- | -80.69 | -- | 10.89 | -- | -- | -- |
| Predilife SA | 728.07k | -3.80m | 12.62m | 27.00 | -- | -- | -- | 17.33 | -0.9936 | -0.9936 | 0.1905 | -1.26 | 0.3919 | -- | 3.63 | 36,421.71 | -204.34 | -93.24 | -- | -132.80 | 98.10 | 89.32 | -521.48 | -1,377.00 | -- | -19.99 | -- | -- | 55.20 | 84.82 | -0.9621 | -- | -24.35 | -- |
| Nfl Biosciences SAS | 0.00 | -3.15m | 14.80m | 4.00 | -- | 4.33 | -- | -- | -0.2779 | -0.2779 | 0.00 | 0.2699 | 0.00 | -- | -- | 0.00 | -66.86 | -75.08 | -91.01 | -121.22 | -- | -- | -- | -- | -- | -- | 0.0088 | -- | -- | -- | 44.44 | -- | -- | -- |
| Poxel SA | 7.66m | -13.66m | 15.70m | 5.00 | -- | -- | -- | 2.05 | -0.2594 | -0.2594 | 0.1443 | -1.14 | 1.45 | -- | 8.90 | 1,276,167.00 | -258.08 | -69.11 | -- | -133.51 | 52.02 | 80.83 | -178.45 | -475.98 | -- | -0.1862 | -- | -- | 234.98 | -24.22 | 47.83 | -- | -- | -- |
| Gensight Biologics SA | 194.00k | -15.12m | 17.52m | 13.00 | -- | -- | -- | 90.29 | -0.1293 | -0.1293 | 0.0016 | -0.245 | 0.0174 | -- | 10.78 | 16,166.67 | -135.38 | -81.19 | -- | -203.71 | -- | -- | -7,793.81 | -868.76 | -- | -- | -- | -- | 18.39 | 16.47 | 46.60 | -- | -57.94 | -- |
| Valbiotis SA | 472.00k | -11.12m | 26.54m | 44.00 | -- | 2.25 | -- | 56.23 | -0.6994 | -0.6994 | 0.0297 | 0.4967 | 0.0206 | 1.57 | 4.89 | 10,727.27 | -48.58 | -33.12 | -61.97 | -47.09 | -603.81 | 19.74 | -2,354.87 | -464.77 | 2.93 | -74.38 | 0.3129 | -- | -96.30 | 13.97 | -36.06 | -- | -2.02 | -- |
| Novacyt SA | 21.95m | -31.90m | 27.73m | 234.00 | -- | 0.5902 | -- | 1.26 | -0.4519 | -0.4949 | 0.3112 | 0.6652 | 0.2354 | 2.34 | 5.27 | 93,804.38 | -34.20 | 5.59 | -39.09 | 7.29 | 63.35 | 66.74 | -145.32 | 9.83 | 4.59 | -7.23 | 0.2114 | -- | 84.82 | 11.35 | -60.50 | -- | 55.60 | -- |
| genOway SA | 20.95m | 1.29m | 30.49m | 148.00 | 16.14 | 1.13 | 7.54 | 1.46 | 0.1487 | 0.1487 | 2.42 | 2.12 | 0.594 | 0.8797 | 3.69 | 146,514.10 | 3.65 | 2.10 | 4.72 | 2.91 | 94.91 | 94.80 | 6.14 | 3.76 | 2.21 | -- | 0.4407 | -- | 10.04 | 18.46 | 16.79 | -- | 15.88 | -- |
| Theranexus SA | 0.00 | -2.94m | 31.87m | 10.00 | -- | -- | -- | -- | -0.3641 | -0.3641 | 0.00 | -0.1923 | 0.00 | -- | -- | 0.00 | -66.82 | -44.47 | -148.89 | -50.85 | -- | -- | -- | -- | -- | -37.71 | 2.90 | -- | -- | -- | 74.15 | -- | -56.53 | -- |
| Fermentalg SA | 12.78m | -11.54m | 36.88m | 63.00 | -- | 1.30 | -- | 2.89 | -0.1242 | -0.1242 | 0.1353 | 0.3156 | 0.2472 | 7.91 | 3.29 | 199,734.40 | -17.09 | -18.10 | -21.17 | -20.59 | 20.94 | 25.51 | -69.14 | -147.66 | 1.83 | -- | 0.2368 | -- | 183.32 | 43.52 | 8.99 | -- | -4.91 | -- |
| Eurofins Cerep SA | 40.46m | 7.15m | 81.21m | 207.00 | 11.35 | 1.13 | 8.49 | 2.01 | 1,418.43 | 1,418.43 | 8,027.24 | 14,234.14 | 0.4955 | 1.61 | 4.75 | 195,445.80 | 8.76 | 13.12 | 10.23 | 15.90 | 85.67 | 80.02 | 17.68 | 20.22 | 6.53 | -- | 0.0046 | -- | -8.20 | 5.46 | -6.34 | 10.36 | -- | -- |
| Ose Immunotherapeutics SA | 2.22m | -34.84m | 99.74m | 68.00 | -- | 1.97 | -- | 44.95 | -1.59 | -1.59 | 0.1009 | 2.26 | 0.0181 | -- | 0.4821 | 34,671.88 | -28.42 | -7.66 | -33.45 | -9.27 | -- | -- | -1,569.85 | -26.10 | -- | -- | 0.4331 | -- | 3,646.52 | 26.31 | 262.78 | -- | -25.52 | -- |
Data as of Feb 10 2026. Currency figures normalised to Fermentalg SA's reporting currency: Euro EUR
10.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Moneta Asset Management SASas of 31 Dec 2024 | 5.21m | 5.80% |
| AXA Investment Managers (Paris) SAas of 30 Jan 2026 | 1.40m | 1.56% |
| CDC Croissance SAas of 25 Nov 2025 | 1.34m | 1.49% |
| OFI Invest Asset Management SAas of 29 Jan 2026 | 1.27m | 1.41% |
| HSBC Global Asset Management (France) SAas of 31 Dec 2025 | 246.30k | 0.27% |
| Friedland Gestion SASas of 30 Sep 2025 | 204.90k | 0.23% |
| Chaussier Gestion SAas of 31 Dec 2025 | 140.00k | 0.16% |
| Mandarine Gestion SAas of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 01 Feb 2026Source: FactSet Research Systems Inc.
